These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7510434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]

  • 7. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L, Kratochwil G, Osterrieder N, Knüchel R, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):10-25. PubMed ID: 9300033
    [Abstract] [Full Text] [Related]

  • 8. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F, Stahl-Hennig C, Dittmer U, Wolf H, Wagner R.
    Biol Chem; 1999 Mar 18; 380(3):341-52. PubMed ID: 10223337
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.
    Brand D, Mallet F, Truong C, Roingeard P, Goudeau A, Barin F.
    J Virol Methods; 1995 Feb 18; 51(2-3):153-68. PubMed ID: 7537750
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J, Morrow CD.
    Virology; 1993 Jun 18; 194(2):843-50. PubMed ID: 8503189
    [Abstract] [Full Text] [Related]

  • 12. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.
    Halsey RJ, Tanzer FL, Meyers A, Pillay S, Lynch A, Shephard E, Williamson AL, Rybicki EP.
    Virus Res; 2008 May 18; 133(2):259-68. PubMed ID: 18329748
    [Abstract] [Full Text] [Related]

  • 13. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X, Liu H, Xiao H, Kappes JC.
    Virology; 1996 May 01; 219(1):307-13. PubMed ID: 8623547
    [Abstract] [Full Text] [Related]

  • 14. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H.
    Behring Inst Mitt; 1994 Dec 01; (95):23-34. PubMed ID: 7755506
    [Abstract] [Full Text] [Related]

  • 15. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F, Yao XJ, Göttlinger HG, Bergeron D, Cohen EA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):1-7. PubMed ID: 7648278
    [Abstract] [Full Text] [Related]

  • 16. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R, Böltz T, Deml L, Modrow S, Wolf H.
    J Gen Virol; 1993 Jul 01; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [Abstract] [Full Text] [Related]

  • 17. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.
    Luo L, Li Y, Chang JS, Cho SY, Kim TY, Choi MJ, Cheong HS, Kim HJ, Ahn HJ, Min MK, Chun BH, Jung SM, Woo SG, Park SY, Kang CY.
    Virology; 1998 Jan 20; 240(2):316-25. PubMed ID: 9454705
    [Abstract] [Full Text] [Related]

  • 18. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carrière C, Courcoul M, Vigne R, Spire B, Boulanger P.
    J Gen Virol; 1998 May 20; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [Abstract] [Full Text] [Related]

  • 19. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T, Leschonsky B, Bieler K, Paulus C, Schröder J, Wolf H, Wagner R.
    Virology; 2000 Mar 15; 268(2):294-307. PubMed ID: 10704338
    [Abstract] [Full Text] [Related]

  • 20. High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.
    Buonaguro L, Buonaguro FM, Tornesello ML, Mantas D, Beth-Giraldo E, Wagner R, Michelson S, Prevost MC, Wolf H, Giraldo G.
    Antiviral Res; 2001 Jan 15; 49(1):35-47. PubMed ID: 11166859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.